Vor Biopharma (VOR) Return on Equity [ROE] (2021 - 2025)
Vor Biopharma's Return on Equity [ROE] was -145.76% in Q1 2025, down 57.92 percentage points from -87.84% a year earlier and down 7.90 percentage points from the prior quarter.
Powered by 
Analysis
Vor Biopharma (VOR) Return on Equity [ROE] (2021 - 2025) Analysis & Trends
For FY2024, Return on Equity [ROE] at Vor Biopharma came in at -94.52%, down 35.78 percentage points from FY2023.
- Return on Equity [ROE] shows a three-year change of -6.86 percentage points (FY2021 to FY2024).
- In earlier years, Return on Equity [ROE] was -58.74% in FY2023 (-19.28 pp), -39.45% in FY2022 (+48.21 pp) and -87.66% in FY2021.
- The Q1 2025 figure marks the lowest quarterly Return on Equity [ROE] in data going back to Q1 2021.
- Compared with a year earlier, Return on Equity [ROE] has declined for 12 straight quarters, with an average year-over-year change of -42.56 percentage points over the last eight quarters.
- The best year-over-year quarter for Return on Equity [ROE] over five years was Q1 2022 (a gain of 9.35 percentage points); the worst was Q3 2024 (a drop of 70.59 percentage points).
- Per Business Quant data, VOR's Return on Equity [ROE] in the three quarters before Q1 2025 was -137.85% (Q4 2024), -131.51% (Q3 2024) and -106.82% (Q2 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 74.39% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 19.33% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 5.63% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 21.60% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 72.13% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -31.17% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 4.66% |
| 10 | Vor Biopharma | 1.20 Bn | -692.85 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2025 | -145.62% |
| Dec 31, 2024 | -137.74% |
| Sep 30, 2024 | -131.10% |
| Jun 30, 2024 | -106.49% |
| Mar 31, 2024 | -87.78% |
| Dec 31, 2023 | -71.99% |
| Sep 30, 2023 | -60.45% |
| Jun 30, 2023 | -48.41% |
| Mar 31, 2023 | -40.30% |
| Dec 31, 2022 | -45.37% |
| Sep 30, 2022 | -52.51% |
| Jun 30, 2022 | -44.68% |
| Mar 31, 2022 | -38.46% |
| Dec 31, 2021 | -30.67% |
| Sep 30, 2021 | -27.45% |
| Jun 30, 2021 | -23.02% |
| Mar 31, 2021 | -47.29% |
API Access
Vor Biopharma Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=VOR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "VOR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=VOR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();